Identifying Active Compounds and Mechanisms of Citrus changshan-Huyou Y. B. Chang against URTIs-Associated Inflammation by Network Pharmacology in Combination with Molecular Docking

Table 1

Active compounds screening.

Active compounds
Mol	NAR	TAN	LUT	NOB	HES	AUR
ID	MOL004328	MOL005814	MOL000006	MOL005828	MOL002341	MOL013434
MW	272.27	372.40	286.25	402.43	302.3	298.41
OB (%)	59.29	21.38	36.16	61.67	70.31	25.62
Caco-2	0.28	1.23	0.19	1.05	0.37	1.24
DL	0.21	0.43	0.25	0.52	0.27	0.24
HL	16.98	—	15.94	16.20	15.78	—

MW: molecular weight, OB: oral bioavailability, Caco-2: Caco-2 permeability, DL: drug-likeness, HL: drug half-life, NAR: naringenin, TAN: tangeretin, LUT: luteolin, NOB: nobiletin, HES: hesperetin, and AUR: auraptene.